Primo is constantly looking for new talents willing to learn, grow and shape a better future in a dynamic...
Avec huit investissements à son actif, la société de private equity ArchiMed se donne encore deux belles années pour épuiser son premier fonds...
ArchiMed has acquired four companies: French health ingredients providers HIS and Fytexia; Polyplus, a maker of transfection reagents; and Micromed, a French-Italian neurodiagnostic company.
ArchiMed has acquired a majority controlling stake in Deallus Consulting. No financial terms were disclosed. Based in London, Deallus is a life sciences industry consultant.
ArchiMed has acquired a majority control of RehabWorks as well as a minority stake in Primo Group s.r.l. Financial terms weren’t announced.
ArchiMed has acquired control of Lausanne-based MediStream, a manufacturer and marketer of innovative orthopaedic implants